维普中文期刊产品整合服务
18篇 您的检索式:作者名="Chitnavis"
    题名 作者 年代 出处 被引量
1Posterior lumbar interbody fusion for revision disc surgeryre- view of 50 cases in which carbon fiber cages were im- planted显示文摘Chitnavis B Barbagallo G Selway R 2001J Neurosurg2001,95,2:1
2Serious paediatric head trauma caused by vehicle rear view mirrors显示文摘Mobasheri R Chitnavis B Bhattee G 2005Emerg Med J2005,,:1
3Posterior lumbar interbody fusion for revision disc surgery显示文摘Chitnavis B Barbagallo G Selway R 2001J Neurosurg2001,95,2:1
4Pilocytic astrocytoma of the adult: clinical features, radiological features and management 显示文摘Bell D Chitnavis BP Al-Sarraj S 2004Br J Neurosurg2004,18,:1
5Cauda equina syndrome: outcome and implications for management显示文摘Hussain SA Gullan RW Chitnavis BP 2003Br J Neurosurg2003,2,:1
6查看详情显示文摘Khadikar B.M Gaikar V.G Chitnavis A.A 0,,:1
7Posterior lumbar interbody fusion for revision disc surgery:review of 50 cases in which carbon fiber cages were implanted显示文摘Chitnavis B Barbagallo G Selway R 2001Neurosurg2001,95,2:1
8Pilocytic astrocytomaof the adult-clinical features,radiological features and management显示文摘Bell D Chitnavis BP Al-Sarraj S 0,,:1
9Cauda equina syn-drome:outcome and implications formanagement显示文摘Hussain SA Gullan RW Chitnavis BP 2003Br JNeu-rosurg2003,17,2:1
10Cauda equina syndrome:outcome and implications for management显示文摘Hussain SA Gullan RW Chitnavis BP 2003Br J Neurosurg2003,2,:1
11Cauda equina syndrome:outcome and implications for management显示文摘Hussain S Gullan R Chitnavis B 2003British Journal of Neurosurgery2003,17,2:1
12Posterior lumbar interbody fusion for revision disc surgery:review of 50 cases in which carbon fiber cages were implanted显示文摘Chitnavis B Barbagallo G Selway R 2001J Neurosurg2001,95,:1
13Posterior lumbar interbody fusion for revision disc surgery显示文摘Chitnavis B Barbagallo G Selway R 2001J Neurosurg2001,95,2:1
14Cauda equi- na syndrome:outcome and implications for management 显示文摘HUSSAIN S A GULLAN R W CHITNAVIS B P 2003Br J Neurosurg2003,17,2:1
15Cauda equina syndrome:outcome and implications for management显示文摘Hussain SA Gullan RW Chitnavis BP 2003Br J Neurosurg2003,17,2:1
16Total thoracic vertebrectomy with anterior and posterior column reconstruction via single posterior approach显示文摘Crocker M Chitnavis B 2007Br J Neurosurg2007,21,1:1
17Osteochondritis dissecans of the knee;long-tenn clinical outcome following arthroscopic debridement显示文摘Murray JR Chitnavis J Dixon P 2007Knee2007,14,2:1
18Opioid use and misuse in ulcerative colitis显示文摘BACKGROUND Patients with ulcerative colitis(UC) may be exposed to opioids over their disease duration. The use of such medications carries significant risk, including intestinal dysmotility and potential for addiction. However, the rates of narcotic use and misuse in patients with UC have not been studied extensively. Functional gastrointestinal disorders(FGID) are prevalent in patients with UC, and have been shown to increase the risk of narcotic use and misuse in patients with Crohn's disease. We hypothesized that patients with UC and a concurrent diagnosis of FGID would have increased rates of both opioid use and misuse in our patient cohort.AIM To evaluate the prevalence of chronic opioid use and misuse in UC.METHODS A retrospective chart review of UC patients seen at the University of Virginia Digestive Health Center was performed on all patients evaluated between 2006 and 2011. Patient demographics, medical, surgical, and medication histories were obtained from the electronic medical record. Concomitant diagnosis of FGID was also noted at the time. The electronic prescription monitoring program was accessed to obtain prescription opioid filling histories. Prescription opioid misuse was defined as opioid prescriptions filled from four or more prescribers and four or more different pharmacies in a 12-mo period.RESULTS A total of 497 patients with UC were included. Patients with UC and FGID were more likely to be female, but no other demographic variables were associated with FGID. Of the UC patients who had FGID, a greater proportion were found to be using opioids chronically(36% with FGID vs 9% without FGID, P < 0.0001)and were misusing prescription opioids(12.8% vs 1.3%, P < 0.001). Multivariate logistic regression demonstrated a significant association with FGID and chronic opioid use(OR = 4.50; 95%CI: 1.91-10.59) and opioid misuse(OR = 5.19; 95%CI1.04-25.76). Tobacco use(OR 2.53; 95%CI: 1.06-6.08) and anxiety(OR 3.17; 95%CI:1.08-9.26) were other variables associated with an increased risk of chronic narcotic use.CONCLUSION FGID was associated with a 4.5-fold increase in chronic opioid use and a 5-fold increased risk of opioid misuse in this patient cohort with UC.Maithili V Chitnavis Merwise Baray Patrick G Northup Anne G Tuskey Brian W Behm 2019World Journal of Gastrointestinal Pharmacology and Therapeutics2019,10,1:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费